4 completed. 2 Not applicable, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow AndoSan: new trials by email Literature Review of AndoSan trials Research Report on AndoSan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Andosan in Allergic and Asthma Patients Andosan, Placebo - Allergic Asthma, Allergic Rhinoconjunctivitis | Not applicable | Completed | University Hospital, Akershus | 34 | 2021-08-31 | 2024-06-18 |
| Does Medicinal Mushroom Agaricus Blazei Protect Against Allergy and Asthma? Agaricus blazei Murill-based mushroom extract, Andosan™, Placebo - Pollen; Allergy, Asthma | Not applicable | Completed | Oslo University Hospital | 60 | 2016-02-01 | 2017-06-26 |
| Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) AndoSan, Sugar Extract - Ulcerative Colitis, Crohn's Disease | Phase 2 / Phase 3 | Completed | Oslo University Hospital | 100 | 2011-12-01 | 2020-10-08 |
| Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD) AndoSan - Inflammatory Bowel Disease | Phase 2 | Completed | Ullevaal University Hospital | 20 | 2009-03-01 | 2011-07-19 |
Inflammatory Bowel Diseases (2) · Asthma (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Hypersensitivity (1)
Oslo University Hospital (2) · Ullevaal University Hospital (1) · University Hospital, Akershus (1)
Norway (3)
Egil Johnson, MD. Phd (1) · Faiza Mahmood (1)